Liposuction study reveals hidden blood risks
NCT ID NCT04656054
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This completed study looked at 20 women who had large-volume liposuction (5–8 liters) to see how removing fat from different body surface areas affects hemoglobin, clotting, and electrolyte levels. The goal was to understand safety risks better. The study did not test a new treatment but aimed to gather knowledge for safer procedures.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- liposuction (procedure)
- What this could lead to
- If successful, this could help surgeons better understand how to reduce risks during large-volume liposuction.
- What could go wrong
- This is a very small, completed study (20 participants) that only observes changes—it does not test a new treatment or offer direct patient benefit.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIPODYSTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Assuit University
Asyut, Assuit, 71515, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?